11 Results for "

WLSEAGPVVTVRALRGTGSW

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "WLSEAGPVVTVRALRGTGSW" in MCE Product Catalog:

Cat. No.: HY-P3436
CAS No.: 771479-86-8
Target:  

Exosomes

Research Areas:  

Cardiovascular Disease

WLSEAGPVVTVRALRGTGSW is a cardiomyocyte-targeting peptide that specifically recognizes tenascin X on the surface of cardiomyocytes. WLSEAGPVVTVRALRGTGSW can serve as a targeting ligand to conjugate with various therapeutic carriers (drugs, genes, exosomes, nanoparticles, etc.) for research on cardiovascular diseases (such as myocardial infarction, heart failure) .
loading...
    loading...
Cat. No.: HY-177204
DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW is a polypeptide targeting tenascin-X (Tenascin-X) that can be conjugated with liposomes and exosomes. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW specifically binds to Tenascin-X on the surface of cardiomyocytes, mediates receptor-dependent uptake of nanocarriers, enhances targeted drug delivery of cargo to cardiomyocytes, and increases drug accumulation in cardiac tissue. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW protects cardiomyocytes treated with LPS, alleviates oxidative stress, repairs mitochondrial function, inhibits ferroptosis and apoptosis, and downregulates the secretion of pro-inflammatory cytokines at the same time. DSPE-PEG2000-WLSEAGPVVTVRALRGTGSW improves cardiac injury and pathological morphology in mice with sepsis-induced cardiomyopathy, restores GPX4 expression, and promotes the internalization of cardiomyocyte-derived exosomes, making it suitable for related research on sepsis-induced cardiomyopathy, myocardial ischemia-reperfusion injury, and other conditions .
loading...
    loading...
Cat. No.: HY-P3436A
Target:  

Exosomes

Research Areas:  

Cardiovascular Disease

WLSEAGPVVTVRALRGTGSW TFA is a cardiomyocyte-targeting peptide that specifically recognizes tenascin X on the surface of cardiomyocytes. WLSEAGPVVTVRALRGTGSW TFA can serve as a targeting ligand to conjugate with various therapeutic carriers (drugs, genes, exosomes, nanoparticles, etc.) for research on cardiovascular diseases (such as myocardial infarction, heart failure) .
loading...
    loading...
Cat. No.: HY-P3425
CAS No.: 154485-78-6
Target:  

Parasite

Research Areas:  

Infection

AGPV, a tetrapeptide, has the potential for prevention of schistosome parasite infection research .
loading...
    loading...
Cat. No.: HY-P3425A
Target:  

Parasite

Research Areas:  

Infection

AGPV TFA, a tetrapeptide, has the potential for prevention of schistosome parasite infection research .
loading...
    loading...
Cat. No.: HY-177204A
Target:  

Liposome

Research Areas:  

Cardiovascular Disease

DSPE-PEG1000-WLSEAGPVVTVRALRGTGSW is a PEG compound which composed of DSPE and a cardiomyocyte specific peptide (WLSEAGPVVTVRALRGTGSW) (HY-P3436). WLSEAGPVVTVRALRGTGSW exhibits high cardiomyocyte targeting primarily through selective binding to specific receptors or molecules on the surface of cardiomyocytes. DSPE-PEG1000-WLSEAGPVVTVRALRGTGSW can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-177204B
Target:  

Liposome

Research Areas:  

Cardiovascular Disease

DSPE-PEG3400-WLSEAGPVVTVRALRGTGSW is a PEG compound which composed of DSPE and a cardiomyocyte specific peptide (WLSEAGPVVTVRALRGTGSW) (HY-P3436). WLSEAGPVVTVRALRGTGSW exhibits high cardiomyocyte targeting primarily through selective binding to specific receptors or molecules on the surface of cardiomyocytes. DSPE-PEG3400-WLSEAGPVVTVRALRGTGSW can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-177204C
Target:  

Liposome

Research Areas:  

Cardiovascular Disease

DSPE-PEG5000-WLSEAGPVVTVRALRGTGSW is a PEG compound which composed of DSPE and a cardiomyocyte specific peptide (WLSEAGPVVTVRALRGTGSW) (HY-P3436). WLSEAGPVVTVRALRGTGSW exhibits high cardiomyocyte targeting primarily through selective binding to specific receptors or molecules on the surface of cardiomyocytes. DSPE-PEG5000-WLSEAGPVVTVRALRGTGSW can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-187498A
Research Areas:  

Others

DOPE-PEG2000-WLSEAGPVVTVRALRGTGSW is an amphiphilic lipid-PEG-peptide conjugate consisting of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the WLSEAGPVVTVRALRGTGSW peptide, a 20-amino-acid targeting peptide identified through phage display. DOPE-PEG2000-WLSEAGPVVTVRALRGTGSW is used for targeted drug delivery via liposome and nanoparticle functionalization.
loading...
    loading...
Cat. No.: HY-187782A
Research Areas:  

Cardiovascular Disease

DPPE-PEG2000-WLSEAGPVVTVRALRGTGSW is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dispalmitoyl-sn-glycerol-3-phosphoethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the WLSEAGPVVTVRALRGTGSW (HY-P3436) peptide as a terminal targeting/functional ligand. DPPE-PEG2000-WLSEAGPVVTVRALRGTGSW can be used in research on targeted drug delivery for cardiovascular diseases (such as myocardial infarction and heart failure) .
loading...
    loading...
Cat. No.: HY-P3436B
Target:  

Connective Peptide

Research Areas:  

Cardiovascular Disease

Cys-PCM is a cardiomyocyte-targeting peptide (PCM) derived from WLSEAGPVVTVRALRGTGSW (HY-P3436) with a cysteine at the N-terminus for conjugation .
loading...
    loading...
  • 1